No shortage on file

SANDOZ LOSARTAN HCT

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of SANDOZ LOSARTAN HCT in Canada?

No. There is no current shortage of SANDOZ LOSARTAN HCT 100MG 12.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-13

DIN

02362449

Strength

100MG 12.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History

2026-10-06

Resolved

Disruption of the manufacture of the drug.

2026-07-07

Resolved

Demand increase for the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495937

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495910

ANGIOMAX

250MG · DIN 02246533

ARGATROBAN

1MG · DIN 02548968

ARSENIC TRIOXIDE FOR INJECTION

10MG · DIN 02513420

ATRACURIUM BESYLATE INJECTION

10MG · DIN 02236759